drugset / Trial / NCT02237443

Mask Ventilation Before and After Neuromuscular Blockade

NCT02237443

Phase 4 Completed 210 enrolled University of Washington
NaSingle-groupOpen-labelTreatment

Summary

Anesthesia providers are taught to "test" that they can properly ventilate a patient's lungs before administering a neuromuscular blocking drug (NMBD), rendering the patient apneic. This is a traditional teaching, not based on empirical evidence. The investigators primary hypothesis is that ventilation after the administration of NMBDs is non-inferior with that before their administration with respect to the composite safety endpoint of inadequate (MVi) and dead-space only (Vds) ventilation.

Timeline

Start
2014-08
Primary completion
2014-11
Completion
2015-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Rocuronium Other / unclassified
Subject Suxamethonium Other / unclassified
Subject Vecuronium Small molecule

Indications

No indication recorded.